Viking Therapeutics
VKTX
#3883
Rank
A$5.00 B
Marketcap
A$39.23
Share price
-2.64%
Change (1 day)
-32.38%
Change (1 year)

EPS for Viking Therapeutics (VKTX)

EPS in 2026 (TTM): A-$7.86

According to Viking Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$8.09. In 2025 the company made an earnings per share (EPS) of A-$4.77 a decrease over its 2024 EPS that were of A-$1.50.

EPS history for Viking Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$7.8664.95%
2025A-$4.77218%
2024A-$1.50
2022A-$1.3626.39%
2021A-$1.0833.33%
2020A-$0.81
2018A-$0.58-51.25%
2017A-$1.20-20%
2016A-$1.50-64.08%
2015A-$4.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
A-$7.78-3.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A-$0.30-96.30%๐Ÿ‡บ๐Ÿ‡ธ USA